A Simple Sandwich Electrochemical Immunosensor for Rapid Detection of the Alzheimer's Disease Biomarker Tau Protein

Mingzhu Yang,Yihong Chen,Hongyu Sun,Dujuan Li,Yanbin Li

DOI: https://doi.org/10.3390/bios14060279

2024-05-30

Biosensors

Abstract:As a typical biomarker of Alzheimer's disease, rapid and specific detection of tau protein can help improve the early diagnosis and prognosis of the disease. In this study, a simple sandwich electrochemical immunosensor was developed for rapid detection of tau protein. Primary monoclonal antibodies (mAb1) against the middle domain of tau protein (amino acids 189–195) were immobilized on the gold electrode surface through a self-assembled monolayer (SAM) of 3,3′-dithiobis (sulfosuccinimidyl propionate) (DTSSP). Then the tau protein was captured through the specific adsorption between the antigen and the antibody, resulting in a change in the impedance. Secondary monoclonal antibodies (mAb2) against the N-terminal region of tau protein were used for further amplification of the binding reaction between mAb1 and tau protein. A linear correlation between the total change in impedance and the logarithm of tau concentration was found from 2 × 10−6 mg mL−1 to 2 × 10−3 mg mL−1, with a detection limit as low as 1 × 10−6 mg mL−1. No significant interference was observed from human serum albumin. Furthermore, the fabricated sandwich immunosensor successfully detected target tau protein in artificial cerebrospinal fluid (aCSF) samples, indicating good potential for clinical applications in the future.

nanoscience & nanotechnology,instruments & instrumentation,chemistry, analytical

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of a simple and rapid method for detecting the Alzheimer's disease (AD) biomarker—tau protein. Specifically, the research team developed a "sandwich" structure based on an electrochemical immunosensor for the rapid detection of tau protein. This method aims to improve the accuracy of early diagnosis and prognosis, thereby enhancing the treatment and management of Alzheimer's disease.

### Main Contributions of the Paper:
1. **Rapid Detection**: Through electrochemical methods, rapid detection of tau protein was achieved, offering faster detection speed compared to traditional methods like enzyme-linked immunosorbent assay (ELISA).
2. **High Sensitivity**: The sensor's detection limit is as low as 1 × 10^-6 mg/mL, with a linear range from 2 × 10^-6 mg/mL to 2 × 10^-3 mg/mL, demonstrating high sensitivity.
3. **Anti-Interference**: The target tau protein was successfully detected in artificial cerebrospinal fluid (aCSF) samples, indicating good clinical application potential and significant resistance to interference from human serum albumin.
4. **Simplicity and Ease of Use**: The sensor preparation process is relatively simple, suitable for point-of-care (POCT) testing, reducing dependence on large and expensive equipment.

### Research Background:
- **Importance of Tau Protein**: Tau protein is an important biomarker for Alzheimer's disease, present in brain neurons, and binds to neural microtubules, maintaining neuron growth, polarity, and intracellular material transport. Under pathological conditions, tau protein undergoes complex post-translational modifications (PTMs), leading to its dissociation from microtubules and aggregation into neurofibrillary tangles and helical filaments, causing neurodegenerative diseases.
- **Limitations of Existing Detection Methods**: Traditional ELISA methods, although widely used, have drawbacks such as expensive equipment, complex operation, and long detection times. Therefore, developing a simple, rapid, and highly sensitive detection method is particularly important.

### Method Overview:
- **Sensor Preparation**: First, the gold electrode surface is modified with a bifunctional molecule DTSSP using self-assembled monolayer (SAM) technology, and then the primary antibody (mAb1) targeting the mid-region of tau protein (amino acids 189-195) is immobilized on the electrode surface. Next, tau protein is specifically captured through adsorption, followed by the addition of a secondary antibody (mAb2) targeting the N-terminal region of tau protein for signal amplification.
- **Electrochemical Characterization**: The sensor's electron transfer rate changes were characterized using electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV), validating the sensor's performance.

### Results and Discussion:
- **Sensor Performance Optimization**: By optimizing the incubation time of DTSSP and the concentrations of the primary antibody (mAb1) and secondary antibody (mAb2), the detection sensitivity and stability of the sensor were improved.
- **Potential for Practical Application**: The successful detection of tau protein in artificial cerebrospinal fluid samples indicates good clinical application prospects for the sensor.

In summary, this study developed a simple, rapid, and highly sensitive electrochemical immunosensor, providing a new tool for the early diagnosis and prognosis of Alzheimer's disease.